Cargando…
Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: What Is Defined, What Is New, and What Is Unmet
The burden of diabetic cardiovascular autonomic neuropathy (CAN) is expected to increase due to the diabetes epidemic and its early and widespread appearance. CAN has a definite prognostic role for mortality and cardiovascular morbidity. Putative mechanisms for this are tachycardia, QT interval prol...
Autor principal: | Spallone, Vincenza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387879/ https://www.ncbi.nlm.nih.gov/pubmed/30793549 http://dx.doi.org/10.4093/dmj.2018.0259 |
Ejemplares similares
-
What Is in the Field for Genetics and Epigenetics of Diabetic Neuropathy: The Role of MicroRNAs
por: Spallone, V., et al.
Publicado: (2021) -
Diabetes update: What's new, what's interesting
por: T. Bloomgarden, Zachary
Publicado: (2022) -
What is the ideal biological marker in diagnosis of diabetic neuropathies?
por: Jin, Heung Yong, et al.
Publicado: (2013) -
What’s New in Neuropathy?
por: Varrassi, Giustino, et al.
Publicado: (2023) -
An update on the diagnosis and treatment of diabetic somatic and autonomic neuropathy
por: Azmi, Shazli, et al.
Publicado: (2019)